Research study for adults with recurrent prostate cancer

IRB/UVA Tracking #
Principal Investigator
Timothy Showalter
Songserea Wood
Contact Phone
Official Trial Title
F-SHARP- A Phase I/II trial of Focal Salvage High dose-rate Brachytherapy for Locally Recurrent Prostate Cancer in Patients Treated with Prior Radiotherapy
Study Description

The Department of Radiation Oncology seeks men ages 18 and older with locally recurrent prostate cancer for a research study. The purpose of the study is to out if having brachytherapy treatment (internal radiation procedure), in one or two treatments, is safe and effective. This study is also looking at patient outcomes, quality of life and overall survival for patients receiving this treatment.

You may be eligible for this study if you have been diagnosed with locally recurrent prostate cancer previously treated with radiation and plan on receiving brachytherapy for treatment.

This study involves receiving 1-2 doses of brachytherapy with or without androgen deprivation therapy. Participants will be asked to complete questionnaires on sexual function, urinary and bowel symptoms during treatment and follow up visits. Clinic follow ups will occur 3 months, 1 year and 2 year after radiation treatment.
Study-related questionnaires will be provided at no cost.


No Compensation